Skip to main content
Clinical Trials/JPRN-UMIN000026558
JPRN-UMIN000026558
Recruiting
N/A

A multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study - A multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study

agoya University Hospital0 sites5,000 target enrollmentMarch 17, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
agoya University Hospital
Enrollment
5000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2017
End Date
March 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
agoya University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who receive or have received biologics for any disease other than rheumatoid arthritis 2\) Patients judged as inadequate at the discretion of physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials